Research ArticleNuclear Oncology
Evaluating Benign and Malignant Bone and Soft-Tissue Lesions with Technetium-99m-MIBI Scintigraphy
Junichi Taki, Junichi Sumiya, Hiroyuki Tsuchiya, Katsuro Tomita, Akitaka Nonomura and Norihisa Tonami
Journal of Nuclear Medicine April 1997, 38 (4) 501-506;
Junichi Taki
Junichi Sumiya
Hiroyuki Tsuchiya
Katsuro Tomita
Akitaka Nonomura
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Evaluating Benign and Malignant Bone and Soft-Tissue Lesions with Technetium-99m-MIBI Scintigraphy
Junichi Taki, Junichi Sumiya, Hiroyuki Tsuchiya, Katsuro Tomita, Akitaka Nonomura, Norihisa Tonami
Journal of Nuclear Medicine Apr 1997, 38 (4) 501-506;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Efficacy and Limitations of F-18-fluoro-2-deoxy-D-glucose Positron Emission Tomography to Differentiate Between Malignant and Benign Bone and Soft Tissue Tumors
- Interpretation of scintigraphic findings of oral malignant tumours with a new scanning agent of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (Tc-99m-MIBI)
- Expression of permeability-glycoprotein (P-gp) and uptake of technetium-99m-hexakis-2-methoxy-isobutyl-isonitrile (99Tcm-MIBI) in malignant tumour of the head and neck
- Scintigraphy for interpretation of malignant tumours of the head and neck: comparison of technetium-99m-hexakis-2-methoxyisobutylisonitrile (Tc-MIBI) and thallium-201-chloride (Tl-201)
- Predicting the Outcome of Distraction Osteogenesis by 3-Phase Bone Scintigraphy
- 99mTc-MIBI Scintigraphy in Musculoskeletal Tumors